日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncogenic β-catenin stimulation of cofilin 1-mediated macropinocytosis is druggable for cancer.

致癌β-catenin刺激cofilin 1介导的巨胞饮作用可作为抗癌药物

Zhang Baohui, Gai Xiaochen, Tang Bufu, Chen Linlin, Wu Yuting, Deng Weiwei, Liu Jiate, Hao Lanting, Liu Fangming, Zhang Hongbing

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

基因组和转录组分析揭示了与套细胞淋巴瘤预后相关的不同分子亚群

Yi, Shuhua; Yan, Yuting; Jin, Meiling; Bhattacharya, Supriyo; Wang, Yi; Wu, Yiming; Yang, Lu; Gine, Eva; Clot, Guillem; Chen, Lu; Yu, Ying; Zou, Dehui; Wang, Jun; Phan, An T; Cui, Rui; Li, Fei; Sun, Qi; Zhai, Qiongli; Wang, Tingyu; Yu, Zhen; Liu, Lanting; Liu, Wei; Lyv, Rui; Sui, Weiwei; Huang, Wenyang; Xiong, Wenjie; Wang, Huijun; Li, Chengwen; Xiao, Zhijian; Hao, Mu; Wang, Jianxiang; Cheng, Tao; Bea, Silvia; Herrera, Alex F; Danilov, Alexey; Campo, Elias; Ngo, Vu N; Qiu, Lugui; Wang, Lili

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy

CRIP1 通过蛋白酶体和自噬的双重调节参与多发性骨髓瘤的发病机制

Peixia Tang, Zhen Yu, Hao Sun, Lanting Liu, Lixin Gong, Teng Fang, Xiyue Sun, Shiyi Xie, Gang An, Zhenshu Xu, Lugui Qiu, Mu Hao

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma

LILRB4 是一种很有前景的免疫治疗靶点,可通过双重靶向肿瘤细胞和髓系来源的抑制细胞来治疗多发性骨髓瘤。

Lixin Gong,Hao Sun,Lanting Liu,Xiyue Sun,Teng Fang,Zhen Yu,Weiwei Sui,Jingyu Xu,Tingyu Wang,Fangshuo Feng,Lei Lei,Wei Rui,Yuxuan Liu,Xueqiang Zhao,Gang An,Xin Lin,Lugui Qiu,Mu Hao

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

DNp73通过靶向MYC和MYCN通路增强多发性骨髓瘤的肿瘤进展和免疫逃逸。

Lanting Liu #,Dasen Gong #,Hao Sun #,Fangshuo Feng,Jie Xu,Xiyue Sun,Lixin Gong,Zhen Yu,Teng Fang,Yan Xu,Rui Lyu,Tingyu Wang,Wentian Wang,Wenzhi Tian,Lugui Qiu,Gang An,Mu Hao

Multiple myeloma-derived miR-27b-3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment

多发性骨髓瘤衍生的 miR-27b-3p 通过促进肿瘤细胞增殖和免疫抑制微环境促进肿瘤进展

Xiaojing Wei, Zhen Yu, Peixia Tang, Hao Sun, Lixin Gong, Lanting Liu, Teng Fang, Yi He, Tingyu Wang, Weiwei Sui, Yan Xu, Gang An, Zhenshu Xu, Xiaoke Ma, Lugui Qiu, Mu Hao

Evaluationof compact air-induction flat fan nozzles for herbicide applications: Spray drift and biological efficacy

评估用于除草剂施用的紧凑型气动扇形喷嘴:喷雾漂移和生物功效

Wang, Shilin; Li, Xinjie; Nuyttens, David; Zhang, Lanting; Liu, Yajia; Li, Xue

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma

多发性骨髓瘤患者血清外泌体 miRNA 分析及预后评估

Teng Fang, Hao Sun, Xiyue Sun, Yi He, Peixia Tang, Lixin Gong, Zhen Yu, Lanting Liu, Shiyi Xie, Tingyu Wang, Zhenshu Xu, Shuhua Yi, Gang An, Yan Xu, Guoqing Zhu, Lugui Qiu, Mu Hao

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

基因组和转录组分析揭示了与套细胞淋巴瘤预后相关的不同分子亚群

Yi, Shuhua; Yan, Yuting; Jin, Meiling; Bhattacharya, Supriyo; Wang, Yi; Wu, Yiming; Yang, Lu; Gine, Eva; Clot, Guillem; Chen, Lu; Yu, Ying; Zou, Dehui; Wang, Jun; Phan, An T; Cui, Rui; Li, Fei; Sun, Qi; Zhai, Qiongli; Wang, Tingyu; Yu, Zhen; Liu, Lanting; Liu, Wei; Lyv, Rui; Sui, Weiwei; Huang, Wenyang; Xiong, Wenjie; Wang, Huijun; Li, Chengwen; Xiao, Zhijian; Hao, Mu; Wang, Jianxiang; Cheng, Tao; Bea, Silvia; Herrera, Alex F; Danilov, Alexey; Campo, Elias; Ngo, Vu N; Qiu, Lugui; Wang, Lili

Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

靛玉红-3'-单肟作为蛋白酶体抑制剂:在多发性骨髓瘤中的治疗应用

Zhen Yu,Xiaojing Wei,Lanting Liu,Hao Sun,Teng Fang,Lu Wang,Ying Li,Weiwei Sui,Kefei Wang,Yi He,Yaozhong Zhao,Wenyang Huang,Gang An,Fancui Meng,Changjiang Huang,Tengteng Yu,Kenneth C Anderson,Tao Cheng,Lugui Qiu,Mu Hao